Molecular mechanisms underlying cardiotoxicity of novel cancer therapeutics

Simon Braumann1, Stephan Baldus1, Roman Pfister1

  • 1Department of Cardiology, Heart Center, University of Cologne, Cologne Cardiovascular Research Center, Cologne, Germany.

Insights

Novel cancer therapies can cause heart failure, known as chemotherapy-induced heart failure (CIHF). Understanding CIHF's molecular basis is key to improving cancer treatments and preventing heart damage.

Area of Science:

  • Oncology
  • Cardiology
  • Pharmacology

Background:

  • Novel cancer therapeutics are improving survival rates but can cause cardiotoxic side effects.
  • Chemotherapy-induced heart failure (CIHF) is a significant concern, impacting long-term patient morbidity and mortality.
  • Understanding the molecular mechanisms of CIHF is crucial for managing these side effects.

Purpose of the Study:

  • To discuss the molecular mechanisms underlying chemotherapy-induced heart failure (CIHF) from novel cancer therapeutics.
  • To provide a synopsis on the clinical management of patients experiencing CIHF.
  • To highlight the importance of understanding CIHF for improving cancer treatment efficacy and patient outcomes.

Main Methods:

  • Review of current literature on molecular mechanisms of CIHF.
  • Synopsis of clinical management strategies for CIHF.
  • Discussion of the interplay between cancer therapy pathways and cardiovascular system.

Main Results:

  • Novel cancer drugs target pathways that can lead to cardiotoxicity, including heart failure.
  • CIHF poses a significant risk to patients undergoing cancer treatment, affecting long-term health.
  • Detailed understanding of molecular pathways is essential for developing targeted interventions.

Conclusions:

  • Further research into the molecular underpinnings of CIHF is necessary.
  • Developing specific interventions to prevent or manage CIHF is critical for optimizing cancer therapy.
  • Integrated approaches combining oncology and cardiology are needed for comprehensive patient care.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K